Revenue, last quarter
$24M
+113.6% vs same quarter last year
Net income
−$74.7M
+24.2% vs same quarter last year
EPS, diluted
−$0.74
+45.2% vs same quarter last year
Operating cash flow
−$33.6M
+7.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $30.9M | −$209.5M |
| FY24 | $10M | −$130.6M |
| FY23 | - | −$87.4M |
| FY22 | $2.6M | −$73.8M |
| FY21 | $2.1M | −$71.2M |
| FY20 | $88.5M | −$67.7M |
| FY19 | $17.5M | −$149.2M |
| FY18 | $26.7M | −$72.4M |
| FY17 | - | −$67.8M |
| FY16 | - | −$36.4M |
| FY15 | - | −$57.9M |
| FY14 | - | −$53.4M |
| FY13 | - | −$41.2M |
| FY12 | - | −$32M |
| FY11 | - | −$13.7M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −550.3% | −677.6% |
| FY24 | −1149.6% | −1306.4% |
| FY23 | - | - |
| FY22 | −2809.6% | −2843.3% |
| FY21 | −2991.2% | −3468.1% |
| FY20 | −55.8% | −76.5% |
| FY19 | −758.1% | −854.8% |
| FY18 | −354.8% | −271.1% |
| FY17 | - | - |
| FY16 | - | - |
| FY15 | - | - |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$104.8M |
| FY23 | - |
| FY22 | - |
| FY21 | −$53.7M |
| FY20 | −$33.5M |
| FY19 | −$138.5M |
| FY18 | −$76M |
| FY17 | - |
| FY16 | −$29.5M |
| FY15 | −$45.8M |
| FY14 | −$39.3M |
| FY13 | −$26.4M |
| FY12 | −$22.9M |
| FY11 | −$10.2M |
- Verastem
- Healthcare median
Show the numbers
| Year | Verastem | Healthcare median |
|---|---|---|
| FY25 | −677.6% | −30.6% |
| FY24 | −1306.4% | −47% |
| FY23 | - | −58% |
| FY22 | −2843.3% | −80.4% |
| FY21 | −3468.1% | −71.8% |
| FY20 | −76.5% | −62.2% |
| FY19 | −854.8% | −46.2% |
| FY18 | −271.1% | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −37.8% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |